ScreenerHero

DIA Diagnostyka S.A.

GPW · PL · Healthcare · Diagnostics & Research · diag.pl
159.10PLN+0.06%Mkt Cap: 1.36B $P/E: 21.07

Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2

Key Statistics

Company
Market Cap1.36B USD
Enterprise Value1.67B USD
Revenue (TTM)654.56M USD
Gross Profit482.57M USD
Net Income (TTM)63.72M USD
Revenue/Share76.56 PLN
Last Price159.10 PLN
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8.6K
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISINPLDGNST00012
Valuation
P/E (Trailing)21.07
P/E (Forward)15.75
PEG—
EV/EBITDA10.87
EV/Revenue2.55
P/S2.08
P/B10.53
EPS (TTM)7.55
EPS (Forward)—
52W Range
146.4021% of range208.00
52W High208.00 PLN
52W Low146.40 PLN
Profitability
Gross Margin79.05%
Oper. Margin13.92%
EBITDA Margin23.46%
Profit Margin10.44%
ROE47.62%
ROA12.16%
Growth
Revenue Growth16.10%
Earnings Growth-10.10%
Cash Flow & Leverage
Operating CF139.74M USD
CapEx (TTM)51.86M USD
FCF Margin7.23%
FCF Yield3.48%
Net Debt304.91M USD
Net Debt/EBITDA1.99
Balance Sheet
Debt/Equity2.05
Current Ratio0.81
Quick Ratio0.70
Book Value/Sh15.11 PLN
Cash/Share0.52 PLN
Dividends
Fwd Div Rate4.40 PLN
Trail. Div Rate4.40 PLN
Div. Yield2.77%
5Y Avg Yield—
Payout Ratio58.28%
Ex-Div DateJun 1, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)196.39 PLN
Upside (mean)+23.4%
Target Range176.00 PLN – 215.00 PLN
176.00+23.4% to mean215.00
# Analysts7
Ownership
Shares Out.33.76M
Float16.40M
Insiders47.20%
Institutions16.75%
Technical
SMA 50165.69 (-4.0%)
SMA 200171.86 (-7.4%)
Beta—
S&P 52W Chg14.58%
Avg Vol (30d)31.50K
Avg Vol (10d)19.35K
Technical Indicators
RSI (14)41.3
MACD-1.9230
MACD Signal-1.6237
MACD Hist.-0.2993
BB Upper168.05 PLN
BB Middle162.31 PLN
BB Lower156.56 PLN
BB Width7.08%
ATR (14)3.673 PLN
Vol Ratio (20d)0.42x